documents: FDA-2008-N-0326-0012
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2008-N-0326-0012 | FDA | FDA-2008-N-0326 | Reference 11 - J. of Antimicrobial Chemotherapy, CTX-M: Changing the Face of ESBLs In Europe re New Animal Drugs; Cephalosporin Drugs; Extralabel Animal Drug Use; Order of Prohibition, FDA-2008-N-0326-0001 - Background | Supporting & Related Material | Background Material | 2008-07-03T04:00:00Z | 2008 | 7 | 2012-07-04T16:56:59Z | 0 | 0 | 090000648064e63a |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref